Drug recall D-0560-2022
Product
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023
Recall details
- Recalling firm
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Quantity
- 115776 bottles
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 14, 2022
- Terminated
- July 31, 2024
Related products
- Moxifloxacin – drug information
- NDC 65862-840 Moxifloxacin · Moxifloxacin Hydrochloride 5 mg/mL · Aurobindo Pharma Limited